Skip to main content
Muthiah Vaduganathan, MD, Cardiology, Boston, MA, Brigham and Women's Hospital

MuthiahVaduganathanMD

Cardiology Boston, MA

Physician

Dr. Vaduganathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Vaduganathan's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2015 - 2019
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Cardiovascular Disease, 2016 - 2017
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2015
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2012

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2015 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Journal Articles

  • Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients with Heart Failure with Reduced Ejection Fraction in US Clinical Practice  
    Muthiah Vaduganathan, Javed Butler, Paul A Heidenreich, Michelle M Kittleson, Anjali Tiku Owens, Pamela N Peterson, Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology
  • Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular Disease  
    Michael C Honigberg, Darren K Mcguire, Muthiah Vaduganathan, JAMA Cardiology
  • Emerging Trends in Financing of Adult Heart Transplantation in the United States  
    Muthiah Vaduganathan, Josef Stehlik, Mandeep R Mehra, JACC: Cardiovascular Imaging
  • Join now to see all

Lectures

  • B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

  • Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Cardiovascular DiseaseJune 2020
  • Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19April 2020
  • Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19April 2020
  • Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients with Type 2 DiabetesMarch 2018
  • Oral Anticoagulation in Patients with Liver DiseaseMarch 2018
  • Join now to see all

Press Mentions

  • More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF
    More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HFMay 22nd, 2023
  • Uptick in Natriuretic Peptides with Long-Term Serial Testing Predicts New Heart Failure
    Uptick in Natriuretic Peptides with Long-Term Serial Testing Predicts New Heart FailureFebruary 14th, 2023
  • Urgency to Expand SGLT2i Use in HF Heightened by More DELIVER Data
    Urgency to Expand SGLT2i Use in HF Heightened by More DELIVER DataOctober 3rd, 2022
  • Join now to see all

Hospital Affiliations